Given the well-established link between calcium dysregulation and neurodegenerative processes, particularly in Alzheimer’s disease [30,31,32,33], this positions PRAJA1 as a key determinant of neuronal vulnerability, and its modulation of L-VGCCs represents a potential therapeutic avenue. This evidence concerns the gene PJA1 and Alzheimer disease.